Compare AANJANEYA LIFECARE with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs DR. REDDYS LAB - Comparison Results

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS DR. REDDYS LAB DR. DATSONS LABS/
DR. REDDYS LAB
 
P/E (TTM) x -10.9 53.3 - View Chart
P/BV x 0.2 5.3 3.0% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 DR. DATSONS LABS   DR. REDDYS LAB
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
DR. REDDYS LAB
Mar-20
DR. DATSONS LABS/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs1263,363 3.7%   
Low Rs312,352 1.3%   
Sales per share (Unadj.) Rs133.01,054.2 12.6%  
Earnings per share (Unadj.) Rs0.2121.9 0.1%  
Cash flow per share (Unadj.) Rs6.6190.2 3.5%  
Dividends per share (Unadj.) Rs025.00 0.0%  
Dividend yield (eoy) %00.9 0.0%  
Book value per share (Unadj.) Rs128.8938.7 13.7%  
Shares outstanding (eoy) m31.66166.17 19.1%   
Bonus/Rights/Conversions FCCBESOP-  
Price / Sales ratio x0.62.7 21.7%   
Avg P/E ratio x516.123.4 2,202.2%  
P/CF ratio (eoy) x11.815.0 78.8%  
Price / Book Value ratio x0.63.0 20.0%  
Dividend payout %020.5 0.0%   
Avg Mkt Cap Rs m2,477474,831 0.5%   
No. of employees `000NA21.7 0.0%   
Total wages/salary Rs m5633,802 0.2%   
Avg. sales/employee Rs ThNM8,091.0-  
Avg. wages/employee Rs ThNM1,561.3-  
Avg. net profit/employee Rs ThNM935.8-  
INCOME DATA
Net Sales Rs m4,211175,170 2.4%  
Other income Rs m796,206 1.3%   
Total revenues Rs m4,289181,376 2.4%   
Gross profit Rs m56924,421 2.3%  
Depreciation Rs m20411,348 1.8%   
Interest Rs m430983 43.8%   
Profit before tax Rs m1318,296 0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2561 -0.3%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6-1,403 -0.4%   
Profit after tax Rs m520,260 0.0%  
Gross profit margin %13.513.9 96.9%  
Effective tax rate %48.0-7.7 -626.4%   
Net profit margin %0.111.6 1.0%  
BALANCE SHEET DATA
Current assets Rs m6,852125,991 5.4%   
Current liabilities Rs m6,71172,141 9.3%   
Net working cap to sales %3.330.7 10.9%  
Current ratio x1.01.7 58.5%  
Inventory Days Days16173 220.1%  
Debtors Days Days318105 304.0%  
Net fixed assets Rs m3,67383,854 4.4%   
Share capital Rs m317831 38.1%   
"Free" reserves Rs m3,761155,157 2.4%   
Net worth Rs m4,078155,988 2.6%   
Long term debt Rs m1,6711,304 128.1%   
Total assets Rs m12,633232,253 5.4%  
Interest coverage x1.019.6 5.2%   
Debt to equity ratio x0.40 4,901.7%  
Sales to assets ratio x0.30.8 44.2%   
Return on assets %3.49.1 37.6%  
Return on equity %0.113.0 0.9%  
Return on capital %7.712.6 60.8%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m96484,193 1.1%   
Fx outflow Rs m60739,616 1.5%   
Net fx Rs m35744,577 0.8%   
CASH FLOW
From Operations Rs m1,34529,841 4.5%  
From Investments Rs m-2,256-4,923 45.8%  
From Financial Activity Rs m-1,200-25,159 4.8%  
Net Cashflow Rs m-2,111-266 793.5%  

Share Holding

Indian Promoters % 4.5 25.5 17.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 5.4 -  
FIIs % 1.4 35.3 3.8%  
ADR/GDR % 0.0 18.5 -  
Free float % 94.1 15.3 615.0%  
Shareholders   20,807 75,885 27.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   PANACEA BIOTECH  BIOCON   FULFORD INDIA  JUBILANT LIFE SCIENCES  AJANTA PHARMA  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Plunges 746 Points; Banking & Metal Stocks Bleed(Closing)

Indian share markets witnessed huge selling pressure today and extended losses as the session progressed, dragged down by heavy selling in metal and banking stocks.

Related Views on News

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

More Views on News

Most Popular

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS